Neurostimulation Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 1972 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL NEUROSTIMULATION DEVICES INDUSTRY
    2.1 Summary about Neurostimulation Devices Industry
    2.2 Neurostimulation Devices Market Trends
        2.2.1 Neurostimulation Devices Production & Consumption Trends
        2.2.2 Neurostimulation Devices Demand Structure Trends
    2.3 Neurostimulation Devices Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Spinal Cord Stimulation (SCS)
        4.2.2 Gastric Electric Stimulation (GES)
        4.2.3 Deep Brain Stimulation (DBS)
        4.2.4 Sacral Nerve Stimulation (SNS)
        4.2.5 Vagus Nerve Stimulation (VNS)
        4.2.6 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Pain Management
        4.3.2 Parkinson's Disease
        4.3.3 Urinary and Fecal Incontinence
        4.3.4 Epilepsy
        4.3.5 Gastroparesis
        4.3.6 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Spinal Cord Stimulation (SCS)
        5.2.2 Gastric Electric Stimulation (GES)
        5.2.3 Deep Brain Stimulation (DBS)
        5.2.4 Sacral Nerve Stimulation (SNS)
        5.2.5 Vagus Nerve Stimulation (VNS)
        5.2.6 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Pain Management
        5.3.2 Parkinson's Disease
        5.3.3 Urinary and Fecal Incontinence
        5.3.4 Epilepsy
        5.3.5 Gastroparesis
        5.3.6 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Spinal Cord Stimulation (SCS)
        6.2.2 Gastric Electric Stimulation (GES)
        6.2.3 Deep Brain Stimulation (DBS)
        6.2.4 Sacral Nerve Stimulation (SNS)
        6.2.5 Vagus Nerve Stimulation (VNS)
        6.2.6 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Pain Management
        6.3.2 Parkinson's Disease
        6.3.3 Urinary and Fecal Incontinence
        6.3.4 Epilepsy
        6.3.5 Gastroparesis
        6.3.6 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Spinal Cord Stimulation (SCS)
        7.2.2 Gastric Electric Stimulation (GES)
        7.2.3 Deep Brain Stimulation (DBS)
        7.2.4 Sacral Nerve Stimulation (SNS)
        7.2.5 Vagus Nerve Stimulation (VNS)
        7.2.6 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Pain Management
        7.3.2 Parkinson's Disease
        7.3.3 Urinary and Fecal Incontinence
        7.3.4 Epilepsy
        7.3.5 Gastroparesis
        7.3.6 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Spinal Cord Stimulation (SCS)
        8.2.2 Gastric Electric Stimulation (GES)
        8.2.3 Deep Brain Stimulation (DBS)
        8.2.4 Sacral Nerve Stimulation (SNS)
        8.2.5 Vagus Nerve Stimulation (VNS)
        8.2.6 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Pain Management
        8.3.2 Parkinson's Disease
        8.3.3 Urinary and Fecal Incontinence
        8.3.4 Epilepsy
        8.3.5 Gastroparesis
        8.3.6 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Spinal Cord Stimulation (SCS)
        9.2.2 Gastric Electric Stimulation (GES)
        9.2.3 Deep Brain Stimulation (DBS)
        9.2.4 Sacral Nerve Stimulation (SNS)
        9.2.5 Vagus Nerve Stimulation (VNS)
        9.2.6 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Pain Management
        9.3.2 Parkinson's Disease
        9.3.3 Urinary and Fecal Incontinence
        9.3.4 Epilepsy
        9.3.5 Gastroparesis
        9.3.6 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Medtronic
        10.1.2 Boston Scientific
        10.1.3 St. Jude Medical
        10.1.4 LiveNova(Cyberonics)
        10.1.5 Nevro
        10.1.6 Inspire Medical Systems
        10.1.7 NeuroPace
        10.1.8 Autonomic Technologies
    10.2  Neurostimulation Devices Sales Date of Major Players (2017-2020e)
        10.2.1 Medtronic
        10.2.2 Boston Scientific
        10.2.3 St. Jude Medical
        10.2.4 LiveNova(Cyberonics)
        10.2.5 Nevro
        10.2.6 Inspire Medical Systems
        10.2.7 NeuroPace
        10.2.8 Autonomic Technologies
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Neurostimulation Devices Product Type Overview
2.Table Neurostimulation Devices Product Type Market Share List
3.Table Neurostimulation Devices Product Type of Major Players
4.Table Brief Introduction of Medtronic
5.Table Brief Introduction of Boston Scientific
6.Table Brief Introduction of St. Jude Medical
7.Table Brief Introduction of LiveNova(Cyberonics)
8.Table Brief Introduction of Nevro
9.Table Brief Introduction of Inspire Medical Systems
10.Table Brief Introduction of NeuroPace
11.Table Brief Introduction of Autonomic Technologies
12.Table Products & Services of Medtronic
13.Table Products & Services of Boston Scientific
14.Table Products & Services of St. Jude Medical
15.Table Products & Services of LiveNova(Cyberonics)
16.Table Products & Services of Nevro
17.Table Products & Services of Inspire Medical Systems
18.Table Products & Services of NeuroPace
19.Table Products & Services of Autonomic Technologies
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Neurostimulation Devices Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Neurostimulation Devices Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Neurostimulation Devices Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Neurostimulation Devices Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Neurostimulation Devices Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Neurostimulation Devices Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Neurostimulation Devices Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Neurostimulation Devices Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Neurostimulation Devices Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Neurostimulation Devices Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Neurostimulation Devices Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Parkinson's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Urinary and Fecal Incontinence Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Epilepsy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Gastroparesis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Parkinson's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Urinary and Fecal Incontinence Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Epilepsy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Gastroparesis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Parkinson's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Urinary and Fecal Incontinence Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Epilepsy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Gastroparesis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Grow
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Neurostimulation Devices Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neurostimulation Devices Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neurostimulation Devices Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports